×
About 26,173 results

ALLMedicine™ Tachycardia Center

Research & Reviews  8,496 results

Aortic root thrombosis leading to STEMI in a Heartmate 3 patient.
https://doi.org/10.1007/s10047-022-01339-y 10.1016/j.healun.2015.10.003 10.1056/NEJMoa1313385 10.1056/NEJMoa1900486 10.1007/s10047-014-0758-0 10.1016/j.healun.2013.10.021 10.1016/j.healun.2013.12.003 10.1111/echo.13425 10.1159/000006834 10.13023/VAD.2015.07
Journal of Artificial Organs : the Official Journal of Th... Ilonze OJ, Torabi A et. al.

May 24th, 2022 - Despite left ventricular assist device (LVAD) therapy becoming established for end-stage heart failure (HF), complications remain. Thromboembolic complications are rare with the newest iteration of LVADs. We managed a case of a continuous-flow LVA...

A Narrow QRS-Complex Tachycardia: What is the Mechanism?
https://doi.org/10.1016/j.hrthm.2022.05.018
Heart Rhythm; Sakai S, Nagashima K et. al.

May 21st, 2022 - A Narrow QRS-Complex Tachycardia: What is the Mechanism?|2022|Sakai S,Nagashima K,Kaneko Y,Maruyama M,|

Preventive VT Substrate Ablation in Ischemic Heart Disease
https://clinicaltrials.gov/ct2/show/NCT04675073

May 20th, 2022 - Fibrotic tissue is known to be the substrate for the appearance of scar-related reentrant ventricular arrhythmias (VA) in chronic ischemic cardiomyopathy (ICM). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) has proven to be a us...

CMR Based Prediction of Ventricular Tachycardia Events in Healed Myocardial Infarction (DEVELOP-VT)
https://clinicaltrials.gov/ct2/show/NCT04599439

May 20th, 2022 - Fibrotic tissue is known to be the substrate for the appearance of scar-related reentrant ventricular arrhythmias (VA) in chronic ischemic cardiomyopathy (ICM). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) has proven to be a us...

Right coronary occlusion due to endocardial ablation for ventricular tachycardia in arr...
https://doi.org/10.1007/s10840-022-01251-8 10.1016/j.hrcr.2017.07.010 10.1016/j.jcmg.2015.03.010 10.31083/j.rcm2204136 10.1016/j.jacc.2013.10.087
Journal of Interventional Cardiac Electrophysiology : an ... Awane R, Takigawa M et. al.

May 20th, 2022 - Right coronary occlusion due to endocardial ablation for ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.|2022|Awane R,Takigawa M,Yonetsu T,Ikenouchi T,Goya M,|

see more →

Guidelines  11 results

Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachyca...
https://doi.org/10.1016/j.jacep.2020.12.001
JACC. Clinical Electrophysiology; Elliott IA, DeJesus M et. al.

Jan 10th, 2021 - Cardiac sympathetic denervation (CSD) for refractory ventricular tachycardia (VT) has been shown to decrease VT recurrence and defibrillator shocks in patients with ischemic and nonischemic cardiomyopathy. Here and in the accompanying Video, we de...

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement o...
https://doi.org/10.1016/j.cjca.2020.04.004
The Canadian Journal of Cardiology; Deyell MW, AbdelWahab A et. al.

Jun 17th, 2020 - This Canadian Cardiovascular Society position statement is focused on the management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that occurs in patients with structural heart disease (SHD), including previous myocar...

Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia ...
https://doi.org/10.1016/j.cjca.2019.12.024
The Canadian Journal of Cardiology; Raj SR, Guzman JC et. al.

Mar 9th, 2020 - The current definition of postural orthostatic tachycardia syndrome (POTS) dates back to a small case series of patients with a subacute illness who presented with excessive orthostatic tachycardia and orthostatic intolerance, in the absence of an...

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324904
Circulation Panchal AR, Berg KM et. al.

Dec 21st, 2018 - Antiarrhythmic medications are commonly administered during and immediately after a ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. However, it is unclear whether these medications improve patient outcomes. This 2018 Ame...

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythm...
https://doi.org/10.1016/j.resuscitation.2018.11.018
Resuscitation Soar J, Perkins GD et. al.

Nov 30th, 2018 - This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular ...

see more →

Drugs  659 results see all →

Clinicaltrials.gov  329 results

CMR Based Prediction of Ventricular Tachycardia Events in Healed Myocardial Infarction (DEVELOP-VT)
https://clinicaltrials.gov/ct2/show/NCT04599439

May 20th, 2022 - Fibrotic tissue is known to be the substrate for the appearance of scar-related reentrant ventricular arrhythmias (VA) in chronic ischemic cardiomyopathy (ICM). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) has proven to be a us...

Preventive VT Substrate Ablation in Ischemic Heart Disease
https://clinicaltrials.gov/ct2/show/NCT04675073

May 20th, 2022 - Fibrotic tissue is known to be the substrate for the appearance of scar-related reentrant ventricular arrhythmias (VA) in chronic ischemic cardiomyopathy (ICM). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) has proven to be a us...

ATrial Tachycardia PAcing Therapy in Congenital Heart
https://clinicaltrials.gov/ct2/show/NCT03209583

May 19th, 2022 - University of Iowa is moving to begin the multi-institutional portion of this study by asking for centers to assist with enrollment so that the investigators can meet our enrollment goal. The investigators wish to recruit a minimum of 250 subjects...

Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia
https://clinicaltrials.gov/ct2/show/NCT04770051

May 19th, 2022 - The purpose of this research study is to examine the effect of percutaneous inferior cervical sympathetic block on life threatening abnormal heart rhythms called ventricular tachycardia or ventricular fibrillation that can lead to sudden cardiac d...

Noninvasive Cardiac Radioablation for Ventricular Tachycardia Refractory to Medication and Catheter Ablation
https://clinicaltrials.gov/ct2/show/NCT04757688

May 18th, 2022 - Ventricular tachycardia (VT) is a regular, rapid (faster than 100 beats per minute) abnormal heart rhythm resulting from aberrant electrical conduction in the ventricles of the heart. Coronary heart disease is responsible for the majority of VT ca...

see more →

News  935 results

How PAs Can Avoid Malpractice: Go Back to Practice Basics
https://www.medscape.com/viewarticle/974472

May 23rd, 2022 - INDIANAPOLIS — Two days after her father was admitted to the hospital from his nursing home with methicillin-resistant Staphylococcus aureus (MRSA), a woman presented to urgent care with fever, chills, chest discomfort, body aches, and mild tachyc...

Management of Post-COVID Cardiac Symptoms
https://www.medscape.com/viewarticle/972410

May 20th, 2022 - This transcript has been edited for clarity. Neil Skolnik, MD: I'm Dr Neil Skolnik, and today we're going to talk about the American College of Cardiology's expert consensus statement on cardiovascular sequelae of COVID-19. Joining us today is Dr ...

Nasal Spray for Converting Paroxysmal SVT Seems Feasible, Safe for Long-term Use
https://www.medscape.com/viewarticle/973808

May 11th, 2022 - A nasal spray that delivers a short-acting calcium-channel blocker (CCB), envisioned as a self-treatment alternative to a pill-in-the-pocket strategy for managing bouts of paroxysmal supraventricular tachycardia (PSVT), has advanced another step i...

43-year-old male • fatigue • unintentional weight loss • pancytopenia • Dx?
https://www.mdedge.com/familymedicine/article/254462/musculoskeletal-disorders
MDedge Family Medicine; Isabella Buzzo Bellon Brout, MD, Caitlin A. Nicholson, MD et. al.

May 10th, 2022 - THE CASE A 43-year-old Black male presented to his primary care physician with an 8-month history of progressive fatigue, weakness, and unintentional weight loss. The patient’s history also included antiphospholipid antibody syndrome (APS) with pr.

FDA Approves Axicabtagene Ciloleucel for Second-Line LBCL
https://www.onclive.com/view/fda-approves-axicabtagene-ciloleucel-for-second-line-lbcl

Apr 28th, 2022 - The FDA has approved axicabtagene ciloleucel (axi-cel; Yescarta) for the treatment of adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy.1 Th...

see more →

Patient Education  39 results see all →